Contract Notice Detail

Summary Information


Base Total Price:	11,151.800000 Euro
Request Reference:	10C0175624
Request Name:	Aquisição de EFEDRINA,IV/IM,50MG/ML;1ML,SOL INJ, ao abrigo do CPA 2021/12, para a ULSASI, para o ano 2024
Phase:	Tendering Phase
State:	Awarded
Description:	Aquisição de EFEDRINA,IV/IM,50MG/ML;1ML,SOL INJ, ao abrigo do CPA 2021/12, para a ULSASI, para o ano 2024
Procedure Type:	VortalGOV - Acquisition under a Framework Agreement (via Direct Award)

Lot Name		Lot Base Price	Expected Duration
E11 - EFEDRINA [50MG; 1 ML; SC-IM; F/AMP]		-	315 (Days)

Object of the Contract

Type of Contract:

Supplies Acquisition

Main Object CPV Main Category:

Ic19 Amadora 2700 Venteira Amadora Lisboa PORTUGAL

CPV Main Vocabulary

33600000-6 - Pharmaceutical products

CPV Supplementary Vocabulary

Additional Classifications List

Scheduling

Request online publishing date:	2/20/2024 11:27 AM (UTC 0 hours)
National official publishing date and time (DR):	10/4/2021 12:00 AM (UTC +1 hour)
Due datetime for receiving replies:	2/23/2024 5:00 PM (UTC 0 hours)

Financial Settings

Define Warranties?

Contract Documents

Document Name	Description	Doc Classification
Anexo II.xlsx	Anexo II.xlsx	Additional Information	Download
Convite_10C0175624.pdf	Convite_10C0175624.pdf	Instruction to tenderers	Download

Object of contract

This contract is subject to renewal?	No
The procurement is related to a project and/or programme financed by European Union funds?	No

Legal, economic, financial and technical information

The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?

Questionnaire

Vision

Título do Lote

E11 - EFEDRINA [50MG; 1 ML; SC-IM; F/AMP]

Preço Base / Valor Estimado

11 151,80

1.1

Bill of Quantities

Esta lista de preços tem requisitos adicionais. Certifique-se de que tudo está completo em cada linha de artigo.

CódigoDescrição QtUnidade

E11

EFEDRINA [50MG; 1 ML; SC-IM; F/AMP]

2 200,000000

Comentários

501169580 | Labesfal - Laboratórios Almiro, S.A. | CPA:2021012/107/0082 | NºAIM:5226196; 510452973 | PLS Pharma, Produtos Farmacêuticos, Lda. | CPA:2021012/757/0006 | NºAIM:5780325;

Totais(Os valores mostrados não incluem IVA)

Evaluation